Skip to content

In the last few years a number of researchers have suggested that microbes may be triggering or somehow causing Alzheimer's disease. Various microbes have been suggested, and research is finding links with herpes viruses, fungi, other microbes, and gum disease (periodontal disease) microbes. Now another study proposes that the common bacteria Porphyromonas gingivalis - which causes chronic periodontal disease, is linked to the development of Alzheimer's disease.

Researchers have suggested that during an initial infection, the "infectious agent" (viruses, etc.) reaches the central nervous system and brain, then stays there in latent form (inactive) for years. And then when the immune system declines with age (which is a normal part of aging) - the microbes (virus, fungi, etc.) become reactivated and cause inflammation and the chain of events leading to Alzheimer's disease.

Note that in the recent study implicating P. gingivalis - the Cortexyme, Inc. company is doing the research and they, of course, are developing a product - so beware of bias. Also, the research done so far is in the earliest stages. But...it is exciting to see if further research (from them and from others) supports some sort of microbe, or several types of microbes, behind the development of Alzheimer's disease. Will we find that there is an "infectious cause" of Alzheimer's disease ("infection-induced neuroinflammation")? Because this means that there is a way to prevent or treat Alzheimer's disease - some sort of antimicrobial, antibiotic, antiviral, or antifungal. Stay tuned for further research.... From Medical Xpress:

Bacterial pathogen Porphyromonas gingivalis may contribute to Alzheimer's disease: Study

Cortexyme, Inc., a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer's disease (AD) and other degenerative disorders, today announced publication of a foundational paper supporting its approach in Science Advances. In the paper, an international team of researchers led by Cortexyme co-founders Stephen Dominy, M.D. and Casey Lynch detail the role of a common bacterium, Porphyromonas gingivalis (Pg), in driving Alzheimer's disease pathology, and demonstrate the potential for small molecule inhibitors to block the pathogen.  ...continue reading "Periodontal Disease Link to Alzheimer’s Disease?"